A103 IPF: MORE ABOUT THERAPY AND OUTCOMES: Safety And Tolerability Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): One-Year Data From Post-Marketing Surveillance In The United States

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2016-01, Vol.193, p.1
Main Authors: Noth, I, Allinger, A, Kaul, M, Conoscenti, C S, Oelberg, D
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1073-449X
1535-4970